Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose

Constanze Kuhlmann; Carla Konstanze Mayer; Mathilda Claassen; Tongai Maponga; Wendy A. Burgers; Roanne Keeton; Catherine Riou; Andrew D. Sutherland; Tasnim Suliman; Megan L. Shaw; Wolfgang Preiser

doi:10.1016/S0140-6736(22)00090-3

Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose

Constanze Kuhlmann, Carla Konstanze Mayer, Mathilda Claassen, Tongai Maponga, Wendy A. Burgers, Roanne Keeton, Catherine Riou, Andrew D. Sutherland, Tasnim Suliman, Megan L. Shaw, Wolfgang Preiser

Research output: Contribution to journal › Letter › peer-review

253 Scopus citations

Original language	English
Pages (from-to)	625-626
Number of pages	2
Journal	The Lancet
Volume	399
Issue number	10325
DOIs	https://doi.org/10.1016/S0140-6736(22)00090-3
State	Published - 12 Feb 2022
Externally published	Yes

Access to Document

10.1016/S0140-6736(22)00090-3

Cite this

@article{8605e99801544d3ba38af708f22e01bc,

title = "Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose",

author = "Constanze Kuhlmann and Mayer, {Carla Konstanze} and Mathilda Claassen and Tongai Maponga and Burgers, {Wendy A.} and Roanne Keeton and Catherine Riou and Sutherland, {Andrew D.} and Tasnim Suliman and Shaw, {Megan L.} and Wolfgang Preiser",

year = "2022",

month = feb,

day = "12",

doi = "10.1016/S0140-6736(22)00090-3",

language = "English",

volume = "399",

pages = "625--626",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "10325",

}

TY - JOUR

T1 - Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose

AU - Kuhlmann, Constanze

AU - Mayer, Carla Konstanze

AU - Claassen, Mathilda

AU - Maponga, Tongai

AU - Burgers, Wendy A.

AU - Keeton, Roanne

AU - Riou, Catherine

AU - Sutherland, Andrew D.

AU - Suliman, Tasnim

AU - Shaw, Megan L.

AU - Preiser, Wolfgang

PY - 2022/2/12

Y1 - 2022/2/12

UR - http://www.scopus.com/inward/record.url?scp=85124284659&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(22)00090-3

DO - 10.1016/S0140-6736(22)00090-3

M3 - Letter

C2 - 35063123

AN - SCOPUS:85124284659

SN - 0140-6736

VL - 399

SP - 625

EP - 626

JO - The Lancet

JF - The Lancet

IS - 10325

ER -